IP Library Granted Patent US 11,066,526
Granted Patent B2
US 11,066,526 · App. 16/066,967 · Granted Jul 20, 2021

Method for cleaving amide bonds

Inventors: Laura Jing Jing (Antibes, FR); Craig Steven Harris (Biot, FR)
Assignee: Galderma Holding SA
C08J3/075A61K8/042A61K8/73A61K8/735A61K9/0019A61Q19/00C07C209/62C07C213/00C07C269/06C07F7/083C08B37/0063C08B37/0069C08B37/0072C08J3/24C08J7/14C08K5/09C08L5/00C08L5/08C07C2603/18C08J2305/00C08J2305/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,066,526
App. No.
16/066,967
Granted
Jul 20, 2021
Kind
B2
Abstract

A method for cleaving amide bonds, comprising: a) providing a molecule comprising an amide group; b) reacting the molecule comprising an amide group with hydroxylamine (NH 2 OH) or a salt thereof to cleave the amide bond of the amide group.

Claims (21)

1. A method for cleaving amide bonds in glycosaminoglycans, the method comprising reacting a glycosaminoglycan (GAG) comprising an N-acyl amide group with hydroxylamine (NH 2 OH) or a salt thereof to cleave the amide bond of the amide group.

2. The method according to claim 1 , further comprising recovering a product formed by the reaction.

3. The method according to claim 1 , wherein the GAG comprises a pH sensitive chiral center.

4. The method according to claim 1 , wherein the GAG comprises a pH sensitive protecting group.

5. The method according to claim 1 , wherein the reacting is at a temperature of 100° C. or less.

6. The method according to claim 1 , wherein the reacting is for 2-200 hours.

7. The method according to claim 1 , wherein the reacting is in water.

8. The method according to claim 1 , wherein having a molar concentration of hydroxylamine in the range of 5-20 M.

9. The method according to claim 1 , wherein the GAG is reacted with a hydroxylamine salt.

10. The method according to claim 9 , wherein the hydroxylamine salt is a salt of hydroxylamine and hydroiodic acid or trifluoroacetic acid.

11. The method according to claim 9 , having a concentration of the hydroxylamine salt in the range of 0.1-5 M.

12. The method according to claim 9 , wherein the reaction is performed in a solvent capable of at least partially dissolving the hydroxylamine salt.

13. The method according to claim 1 , wherein the reaction is performed at a pH value in the range of 4-12.

14. The method according to claim 13 , wherein the reaction is performed at a pH value in the range of 9-11.

15. The method according to claim 13 , further comprising lowering the pH of the reaction to a value in the range of 4-9 by adding a pH reducing agent selected from the group consisting of mineral acids, organic acids and pH reducing salts, and combinations thereof.

16. The method according to claim 15 , wherein the pH reducing agent is a pH reducing salt.

17. The method according to claim 1 , wherein the GAG is selected from hyaluronic acid, hyaluronan, chondroitin, chondroitin sulphate, heparin sulphate, heparosan, heparin, dermatan sulphate, keratin sulphate, and combinations thereof.

18. The method according to claim 17 , wherein the GAG is hyaluronic acid.

19. The method according to claim 1 , wherein the GAG is crosslinked in a hydrogel.

20. The method according to claim 1 , having a concentration of the hydroxylamine salt in the range of 0.1-10 M.

21. The method according to claim 1 , further comprising recovering a product of the reacted GAGs exhibiting a weight average molecular weight of at least about 1,000 kDa.

Assignments (7)
CHANGE OF ADDRESS Recorded Jun 28, 2022
From: GALDERMA HOLDING SA
To: GALDERMA HOLDING SA
Reel/Frame 060541/0374 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNEES ADDRESS PREVIOUSLY RECORDED AT REEL: 057652 FRAME: 0859. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 13, 2021
From: GALDERMA S.A.
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 058495/0582 →
CHANGE OF NAME Recorded Sep 29, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 057631/0589 →
AMENDMENT TO ASSET TRANSFER AGREEMENT Recorded Sep 29, 2021
From: GALDERMA S.A.
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 057652/0859 →
CHANGE OF NAME Recorded Jun 14, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 056537/0623 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2021
From: GALDERMA SA
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 056591/0821 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2018
From: JING, LAURA JING; HARRIS, CRAIG STEVEN
To: GALDERMA S.A
Reel/Frame 046937/0796 →